The medical sector is experiencing a significant shift in glucose care with the emergence of GLP-1 transdermal devices. These innovative delivery systems offer a potentially convenient choice to injections for individuals living with type 2 diabetes. By avoiding the necessity for frequent pokes, GLP-1 adhesives promise to boost individual adherence